> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Labcorp Shares Jump 10% As Lab Operator Lifts Earnings Forecast
- URL: https://www.bullished.co/labcorp-shares-jump-10-as-lab-operator-lifts-earnings-forecast-f82412ce/
- Published: 2026-10-28T14:27:06.000Z
- Updated: 2026-10-28T14:27:06.000Z
- Description: Labcorp now expects $18.30 to $18.70 in adjusted earnings per share for the year, while its CEO flagged a $125 million Medicare fee-cut hit.
- Author: Matteo Parrino
- Tags: Markets, LH, Industry: Healthcare

[Labcorp](https://www.bullished.co/tag/lh/), which runs laboratories that test patient samples and support drug development, saw its shares climb 9.52% to $362.71 in Wednesday trading as of 10:25 a.m. ET, adding $2.6 billion in market value. The jump came on the day it reported [third-quarter revenue of $3.81 billion](https://finance.yahoo.com/healthcare/articles/labcorp-nyse-lh-q3-2026-112126296.html?ref=bullished.co) and raised its full-year profit outlook.

## Raised guidance, adjusted EPS of $4.78

Adjusted earnings came to $4.78 a share in the quarter. Full-year guidance [now spans](https://www.sec.gov/Archives/edgar/data/0000920148/000092014826000213/lh-20261028.htm?ref=bullished.co) $18.30 to $18.70 a share.

The stock was on pace for its biggest one-day gain in at least 275 trading sessions and its third straight daily gain. Its market value stood at $29.4 billion at the intraday reading.

## A $125 million Medicare warning

On the earnings call, CEO Adam Schechter said proposed Medicare cuts to lab fees endanger patient access. The company [sized the hit at $125 million](https://finance.yahoo.com/markets/stocks/articles/labcorp-holdings-lh-q3-earnings-113505740.html?.tsrc=rss&ref=bullished.co).

## A lab giant already up 32%

Labcorp has two segments. Diagnostics, which tests for physicians, hospitals, health plans and patients, produced $10,876.5 million of its $13,951.7 million in 2025 revenue, or 78%. Biopharma Laboratory Services, which supports drug developers, produced $3,098.2 million.

The shares were up about 32% year to date as of Tuesday's close, against about 13% for the S&P 500, and sat within 3% of their highest close of the past year, set on Aug. 24\. The prior quarter's [10-Q](https://www.sec.gov/Archives/edgar/data/920148/000092014826000175/lh-20260630.htm?ref=bullished.co) showed revenue of $3.7 billion, up 5.8% from a year earlier, and net income of $298.7 million.

The $125 million Medicare fee-cut estimate is the number the CEO attached to the risk, set against a guidance range that was just raised.

### Sources

- [Labcorp’s (NYSE:LH) Q3 2026 sales beat estimates](https://finance.yahoo.com/healthcare/articles/labcorp-nyse-lh-q3-2026-112126296.html?ref=bullished.co) — Yahoo Finance
- [Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests](https://finance.yahoo.com/healthcare/articles/waters-labcorp-expand-access-fda-153100731.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [Labcorp Holdings (LH) Q3 Earnings and Revenues Surpass Estimates](https://finance.yahoo.com/markets/stocks/articles/labcorp-holdings-lh-q3-earnings-113505740.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [Healthcare Authority Deals & Corporate Governance : Law360 Healthcare Authority : Legal News & Analysis](https://www.law360.com/healthcare-authority/deals-corporate-governance?article%5Fsidebar=1&ref=bullished.co) — law360.com
- [Labcorp Holdings Inc. (NYSE:LH) : Cases :: Law360](https://www.law360.com/companies/labcorp-holdings-inc/cases?ref=bullished.co) — law360.com
- [Labcorp Lifts Full-Year Profit Outlook As Lab Testing And Drug-Trial Businesses Both Grow](https://www.sec.gov/Archives/edgar/data/0000920148/000092014826000213/lh-20261028.htm?ref=bullished.co) — SEC filing
- [Labcorp Holdings — Form 10-Q for the quarter ended 2026-06-30 (quarterly results)](https://www.sec.gov/Archives/edgar/data/920148/000092014826000175/lh-20260630.htm?ref=bullished.co) — SEC EDGAR

### More on Labcorp Holdings

- [Labcorp Raises 2026 Profit Outlook To $18.30–$18.70 A Share After Third-Quarter Adjusted EPS Climbs 14.5%](https://www.bullished.co/labcorp-raises-2026-profit-outlook-to-18-30-18-70-a-share-after-third-quarter-adjusted-eps-9b692d4b/)

[All Labcorp Holdings (LH) coverage →](https://www.bullished.co/tag/lh/)